Low Concentration Atropine for Myopia Progression in School Children
Status:
Completed
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
Myopia is the leading cause of blindness in Taiwan. The younger children with myopia, the
higher risk of high myopia in later life and complications such as retinal detachment and
maculopathy will occur. We have reported the low concentration of atropine (0.05%) with the
effect on retarding the myopia progression. Recently the 0.01% atropine was also reported
effective and with less visual side effects such as mydriasis. The aim of this study is to
compare the efficacy in controlling myopia progression and visual side effects of 2 low
concentration of atropine(0.05% vs 0.01%) in children aged 6-12 years with myopia of at least
-0.5 diopters (D) and astigmatism of -1.50 D or less.